The Charnley versus the Spectron hip prosthesis: radiographic evaluation of a randomized, prospective study of 2 different hip implants.

A total of 410 hips were randomized to treatment with either a Charnley (206 hips) or a Spectron (204 hips) total hip arthroplasty. The patients were operated on by a standardized procedure using a contemporary cementing technique and were followed after 1, 3, 5 to 6, and 10 years. The postoperative radiographs showed a significantly increased rate of malalignment and consequently low grade of cement mantle quality of the Charnley stem compared to the Spectron. No differences concerning cement mantle quality or positioning were found between the Charnley ogee cup and the metal-backed Spectron. Evaluation of the follow-up radiographs revealed 10 loose Charnley stems and 1 loose Spectron stem and 4 loose Charnley ogee cups and 23 loose Spectron metal-backed cups. The differences of revision rate for the femoral and acetabular components of the 2 prostheses were significant (P = .03, Charnley femoral component more frequent; P = .03, Spectron acetabular component more frequent). The radiographic evaluation strengthened this disparity. Poor wear characteristics of the metal-backed Spectron cup are perhaps the main reason for the highly significant difference in mechanical failure rate between the 2 cups. We therefore propose that metal-backing of cemented cups should be avoided, at least when combined with larger femoral heads. The difficulty in positioning the Charnley stem with an adequate cement mantle, especially in the absence of trochanteric osteotomy, might explain the inferior Charnley stem longevity in this study.     

Survival of hip replacements. A comparison of a randomized trial and a registry

At the authors' hospital, 410 primary total hip replacements were performed on 372 patients between September 1, 1985, and May 31, 1989. All hips were assigned randomly to receive a Charnley prosthesis with an ogee flanged cup or a Spectron prosthesis with a metal backed cup. Eleven-year survivor analysis, using revision as the end point definition of failure, revealed a survival rate of 93.2% +/- 5.8% for the Charnley replacement and 95.9% +/- 3.0% for the Spectron. If each component of the systems was analyzed (concerning aseptic loosening), the ogee cup and the Spectron stem had 100% survival. The survivorship for all 410 hips was 94.5% +/- 3.4%. If the end point definition of failure was expanded to include patient dissatisfaction, the survival rate decreased to 86.3% +/- 4.9%. These survival rates were compared with the rates obtained by the Swedish National Hip Registry. The national cohort included all patients in Sweden who were treated surgically with a Charnley (14,053 patients) or Spectron (metal backed cup) prosthesis (726 patients) between September 1, 1985, and May 31, 1989. Eleven-year survivor analysis revealed a national survival rate of 92.1% +/- 0.7% for the Charnley replacement and 88.6% +/- 6.1% for the Spectron. The analyses from the Swedish Registry are based on more than 160,000 primary operations and 11,500 revisions. Despite the enormous amount of data, there are drawbacks, and registries never can replace the prospective, randomized trial. One reason is the Swedish National Registry is unable to discriminate between the individual cup and stem components when analyzing the cause of revision, and no clinical or radiographic information is collected. A potential drawback for the randomized trial is performance bias because surgeons from specialized centers might perform better than the general orthopaedic surgeon.     

Metallosis after contemporary metal-on-metal total hip arthroplasty. Five to nine-year follow-up

BACKGROUND: Authors of recent studies have reported early periprosthetic osteolysis in patients who have been treated with a contemporary metal-on-metal total hip arthroplasty and have suggested that metal hypersensitivity associated with an immunologic response to metal may be of etiologic importance. We evaluated the results and histologic findings in patients who had undergone revision of a failed contemporary metal-on-metal total hip arthroplasty. METHODS: Two hundred and seventeen total hip arthroplasties (SL-Plus stem and Bicon-Plus cup) with a Sikomet metal-on-metal articulation were implanted in 194 consecutive patients, and the results were retrospectively reviewed at a mean of seventy-seven months postoperatively. Clinical follow-up with the Harris hip score and plain radiographic evaluation were performed. Periprosthetic tissues from fourteen hips that had undergone revision arthroplasty were subjected to histologic analysis. RESULTS: The mean Harris hip score improved from 45 points preoperatively to 88 points at the final evaluation. Fourteen hips (6.5%) were revised: nine because of aseptic loosening, two because of technical failure, and three because of septic failure. Histologic examination of the retrieved periprosthetic tissues from the eleven patients who had undergone revision because of aseptic loosening or technical failure showed metallosis and extensive lymphocytic and plasma-cell infiltration around the metal debris. With removal of the component because of aseptic loosening as the end point, survivorship was 93% for the stem and 98% for the cup. CONCLUSIONS: Our findings are in agreement with those in recent publications and support the possibility that periprosthetic osteolysis and aseptic loosening in hips with a metal-on-metal articulation are possibly associated with hypersensitivity to metal debris. Prospective, comparative, randomized long-term studies are necessary to determine the cause(s) of loosening of prostheses with this particular articulation.     

Medium-term result of Elite Plus hip arthroplasty: the second modular evolution of the original Charnley low-friction arthroplasty

BackgroundThe Elite Plus total hip arthroplasty (THA) system was introduced as the second modular evolution of the original Charnley low-friction arthroplasty. However, the results of the Elite Plus THA are currently considered to be inconsistent. The aim of this study was to clarify the medium-term results and the factors affecting the results of Elite Plus THA.MethodsThe results of 97 Elite Plus THAs in 87 patients at 5 years or more postoperatively were reviewed. The patients’ mean age was 65 years, and follow-up averaged 8.0 years. The Elite Plus stem was used in all hips, and three designs of socket, Hylamer Ogee in 40 hips, Wroblewski Offset Bore in 38, and Charnley Ogee in 19, were implanted. The survival rates with loosening and revision as endpoints were analyzed. To clarify the risk factors affecting the survival rates, Charnley’s functional classification, Bombelli’s classification, Crowe’s classification, structural bone grafting of the acetabulum, cup design, stem position, and grading of the cement mantle were evaluated.ResultsThe stem survival rate with aseptic loosening as the endpoint was 96 %, and the rate with revision was 100 %. The cup survival rate with aseptic loosening as the endpoint was 80 %, and the rate with revision was 93 %. Using a Cox proportional hazards model, cup design was a potential confounding factor for acetabular loosening (p = 0.001). The loosening rates were 31 % for Hylamer Ogee sockets at 9.4 years, 8 % for Wroblewski Offset Bore sockets at 7.4 years, and 0 % for Charnley Ogee sockets at 5.6 years. No factors were significantly related to acetabular revision and femoral loosening.ConclusionsThe results of Elite Plus stem THA were excellent in the medium term. The cup design was a potential confounding factor for acetabular loosening, and the Hylamer Ogee socket was associated with a poor result.     

Hybrid alumina total hip arthroplasty using a press-fit metal-backed socket in patients younger than 55 years. A six- to 11-year evaluation

Between 1990 and 1992, we implanted 71 hybrid alumina-on-alumina hip arthroplasties in 62 consecutive patients under the age of 55 years, with a mean age of 46 years at surgery. There were 56 primary and 15 secondary procedures. The prostheses involved a cemented titanium alloy stem, a 32 mm alumina head, and a press-fit metal-backed socket with an alumina insert. Three patients (four hips) died from unrelated causes. Four hips had revision surgery for either deep infection, unexplained persistent pain, fracture of the alumina head, or aseptic loosening of the socket. The nine-year survival rate was 93.7% with revision for any cause as the end-point and 98.4% with revision for aseptic loosening as the end-point. The outcome in the surviving patients (50 patients, 57 hips) with a minimum five-year follow-up (mean eight years) was excellent in 47 hips (82.5%), very good in eight (14%), good in one and fair in one. A thin, partial, lucent line, mainly in zone III was present in 38% of the sockets and one socket had a complete lucency less than 1 mm thick. One stem had isolated femoral osteolysis. There was no detectable component migration nor acetabular osteolysis. This hybrid arthroplasty gave satisfactory medium-term results in active patients. The press-fit metal-backed socket appeared to have reliable fixation in alumina-on-alumina hip arthroplasty. The excellent results using cemented fixation of the stem may be related to the low production of wear debris.     

18 years of results with cemented primary hip prostheses in the Norwegian Arthroplasty Register: Concerns about some newer implants

Background and purpose Few studies have compared the long-term survival of cemented primary total hip arthroplasties (THAs), and several prostheses have been used without adequate knowledge of their endurance. We studied long-term outcome based on data in the Norwegian Arthroplasty Register.Patients and methods The 10 most used prosthesis brands in 62,305 primary Palacos or Simplex cemented THAs reported to the Register from 1987 through 2007 were included. Survival analyses with revision as endpoint (for any cause or for aseptic loosening) were performed using Kaplan-Meier and multiple Cox regression with time-dependent covariates. Revision rate ratios (RRs) were estimated for the follow-up intervals: 0–5, 6–10, and > 10 years.Results 5 prosthesis brands (cup/stem combinations) (Charnley, Exeter, Titan, Spectron/ITH, Link IP/Lubinus SP; n = 24,728) were investigated with 0–20 year follow-up (inserted 1987–1997). After 18 years, 11% (95% CI: 10.6–12.1) were revised for any cause and 8.4% (7.7–9.1) for aseptic loosening. Beyond 10 years of follow-up, the Charnley cup had a lower revision rate due to aseptic loosening than Exeter (RR = 1.8) and Spectron (RR = 2.4) cups. For stems, beyond 10 years we did not find statistically significant differences comparing Charnley with Titan, ITH, and SP stems, but the Exeter stem had better results (RR = 0.5). 10 prosthesis brands (9 cups in combination with 6 stems; n = 37,577) were investigated with 0–10 years of follow-up (inserted from 1998 through 2007). The Charnley cup had a lower revision rate due to aseptic loosening than all cups except the IP. Beyond 5 years follow-up, the Reflection All-Poly cup had a 14 times higher revision rate. For stems, beyond 5 years the Spectron-EF (RR = 6.1) and Titan (RR = 5.5) stems had higher revision rates due to aseptic loosening than Charnley. The analyses also showed a marked improvement in Charnley results between the periods 1987–1997 and 1998–2007.Interpretation We observed clinically important differences between cemented prosthesis brands and identified inferior results for previously largely undocumented prostheses, including the commonly used prosthesis combination Reflection All-Poly/Spectron-EF. The results were, however, satisfactory according to international standards.     

Twenty-five-year survivorship of two thousand consecutive primary Charnley total hip replacements: factors affecting survivorship of acetabular and femoral components

BACKGROUND: Charnley total hip arthroplasty has been demonstrated to provide good clinical results and a high rate of implant survivorship for twenty years and longer. Most long-term series are not large enough to stratify the many demographic factors that influence implant survivorship. The purpose of this study was to analyze the effects of demographic factors and diagnoses on the long-term survivorship of the acetabular and femoral components used in Charnley total hip arthroplasty. METHODS: Two thousand primary Charnley total hip arthroplasties (1689 patients) were performed at one institution from 1969 to 1971. Patients were contacted at five-year intervals after the arthroplasty. Twenty-five years after the surgery, 1228 patients had died and 461 patients were living. Hips that had not had a reoperation, revision or removal of a component for any reason, or revision or removal for aseptic loosening were considered to have survived. Survivorship data were calculated with use of the method of Kaplan and Meier. Patients were stratified by age, gender, and underlying diagnosis to determine the influence of these factors on implant survivorship. RESULTS: The twenty-five year rates of survivorship free of reoperation, free of revision or removal of the implant for any reason, and free of revision or removal for aseptic loosening were 77.5%, 80.9% and 86.5%, respectively. The twenty-five-year survivorship free of revision for aseptic loosening was poorer for each decade earlier in life at which the procedure was performed; this survivorship ranged from 68.7% for patients who were less than forty years of age to 100% for patients who were eighty years of age or older. Men had a twofold higher rate of revision for aseptic loosening than did women. CONCLUSIONS: Age, gender, and underlying diagnosis all affected the likelihood of long-term survivorship of the acetabular and femoral components used in Charnley total hip arthroplasty.     

Aseptic loosening in metal-backed acetabular components for total hip replacement. A minimum five-year follow-up

We reviewed the cases of thirty-six patients who had forty cemented total hip replacements with the Harris metal-backed acetabular component. The operations were done between 1972 and 1977, and the duration of follow-up averaged 7.6 years (range, five to 10.8 years). The average age of the patients was forty-four years (range, sixteen to sixty-two years). Aseptic loosening of the acetabular component occurred in three hips (7.5 per cent), and three more sockets were revised for other reasons. Two of the three sockets with aseptic loosening were in the fifteen patients (seventeen hips) who were forty-five years old or younger. The remaining loose cup was in one of the twenty-one patients (twenty-three hips) who were forty-six years old or older. The reduction in the rate of aseptic loosening of the socket in our series, compared with the higher rates reported in similar long-term studies in which other acetabular components were used, supports the conclusion that there is enhanced longevity of acetabular fixation when a metal-backed acetabular component is used in cemented total hip arthroplasty.     

A ten-year follow-up study of 170 Charnley total hip arthroplasties

Between 1971 and 1974, 352 low-friction hip arthroplasties were performed on 296 patients using the precise Charnley technique. One hundred seventy hips in 145 patients were followed either for ten years or to the point at which revision of the total hip arthroplasty was made necessary by infection, aseptic loosening, chronic dislocation, or similar complications. The results of this evaluation revealed an overall revision rate to the ten-year level of 8.8% in 171 hips and an infection rate of 1.4% for all 352 cases. Both clinical and radiologic assessments encourage further use of this technique.     

Long-term results of total hip arthroplasty for femoral neck fracture nonunion

BACKGROUND: Hip arthroplasty for the treatment of nonunion at the site of a femoral neck fracture has provided good short-term results. The purpose of the present study was to evaluate the long-term results and complications of total hip arthroplasty for the treatment of femoral neck nonunion. METHODS: The records of ninety-nine patients who had been managed with total hip arthroplasty with use of a cemented Charnley acetabular component and a cemented Charnley monoblock femoral component for the treatment of a femoral neck nonunion were retrospectively reviewed. The average age at the time of the arthroplasty was sixty-eight years. Eighty-four patients (85%) were followed until death, revision, or component removal or for at least two years (mean, 12.2 years) postoperatively. RESULTS: Twelve patients were treated with revision (eleven) or resection arthroplasty (one), eleven were lost to follow-up, and four died less than two years postoperatively. Of the remaining seventy-two unrevised hips that were followed for at least two years, sixty-nine (96%) had no or mild hip pain at the time of the last follow-up. The rate of component survival free of revision or removal for any reason was 93% at ten years and 76% at twenty years. The risk factors that were significantly associated with revision for aseptic loosening included an age of less than sixty-five years at the time of the arthroplasty (p = 0.045), a body-mass index of >/=30 (p < 0.01), and male gender (p = 0.02). The second most common complication after loosening was dislocation, which occurred in nine patients (9%). CONCLUSIONS: Total hip arthroplasty is an effective method for the treatment of nonunion of the femoral neck and provides satisfactory long-term results. However, the rate of implant survival is poorer than that reported in most other studies of Charnley total hip arthroplasty in the general population.     

Primary total hip arthroplasty with an uncemented femoral component five- to nine-year results

This study reports the outcome of total hip arthroplasty with use of an uncemented, tapered stem with a 5- to 9-year follow-up. The first 200 consecutive patients (214 hips) undergoing total hip arthroplasty with the Accolade TMZF stem (Stryker Orthopaedics, Mahwah, NJ) were enrolled prospectively. Follow-up for these patients averaged 7.6 years and encompassed review of clinical records as well as review of serial anteroposterior and lateral radiographs. There were 5 revision surgeries for aseptic loosening, 2 cases of infection, instability, and polyethylene wear. Our failure rate, defined as hips needing revision, was 2.6%, and the failure rate due to aseptic loosening of the femoral component was 0.6%. These results demonstrate the high success rate of this implant providing support for its continued use.     

Sixteen-year follow-up of the cemented spectron femoral stem for hip arthroplasty

Clinical and radiographic follow-up was performed on a consecutive series of 105 patients who underwent 120 total hip arthroplasties at the authors' institution from 1983 to 1988 with a straight, cobalt-chrome femoral stem implanted using a second-generation cementing technique. The mean age at the time of surgery was 68.5 years, and the mean follow-up was 16 years. At 16 years' follow-up, the prevalence of revision for aseptic loosening of the Spectron femoral component was only 4.2%; 5 stems were revised for aseptic loosening at a mean of 10.2 years after implantation. Sixteen-year survivorship of the component was 93.9% +/- 2.7% when revision for aseptic loosening was taken as the endpoint or 90.3% +/- 4.4% when either revision for aseptic loosening or radiographic evidence of loosening was taken as the endpoint.     

Revision arthroplasty of the hip joint

Summary During the period 1974–1983, 768 total hip arthroplasties were performed at the Surgical Hospital, University Central Hospital in Helsinki. Brunswik prostheses were used until 1980, and after this the operations were routinely performed with Lubinus prostheses. Additionally, from 1977 to 1981 Wagner and Freeman resurfacing prostheses were used in 107 cases. Of all these patients, 44 (5.7%) needed revision arthroplasty. The average interval between the primary operation and revision arthroplasty was 3.7 years and the follow-up period after the second operation averaged 2.9 years. The patients who underwent revision arthroplasty were compared with a matched control group. In the revision group, radiographs revealed that the medial cement packing was complete in 28% of the hips, this being the case in 78% of the controls (P < 0.001). Also, the cement tip packing was more often incomplete in the revision hips than in the controls (P < 0.01). Regarding the lateral cement packing there was no statistical difference between the two groups. The revision rate of the resurfacing prostheses was 14.9%, compared with 7.8% of the Brunswik prostheses which were inserted at the same time. At the follow-up, the patients with revised hips had less pain than before the primary operation (P < 0.001) and their mobility was similarly improved. We conclude that adequate medial and tip cement packing must be emphasized in the primary arthroplasty. Resurfacing prostheses have a relatively high loosening tendency. Revision arthroplasty is the treatment of aseptic loosening after total hip replacement and it gives good clinical results.Aseptic loosening is the most common long-term complication after total hip replacement surgery. Clinical loosening rates are mostly judged by the number of patients who have been reoperated on, this probably leading to somewhat low figures. Reports on prosthesis loosening usually concern cemented prostheses, and both analyses based on radiographical evidence and revision rates have been published [1, 3, 4, 10, 12, 14]. It appears that most of the prostheses, at least as concerns femoral components, loosen during the first 5 years, and the numbers increase only slowly between 5 and 10 years postoperatively [16, 17].A certain proportion of prostheses will loosen even when the most progressive operative methods are used, and revision arthroplasties of the hip joint are part of the routine of orthopedic departments. We have analyzed our total hip revision arthroplasties, focusing on the factors leading to prosthesis loosening and on the outcome of hip revision operations.     

Long-term survival of the Charnley low-friction total hip arthroplasty

A survivorship analysis of 1,151 Charnley low-friction total hip arthroplasties performed as a primary procedure showed the following 15-year failure probabilities: hip revision 13%, cup revision 8%, femoral revision 12%, radiographic femoral loosening 13%, and radiographic cup loosening 49%. Pain scores diminished gradually with time so that at 15 years, the probability of a Charnley pain score less than 5 was 70%. The data suggest that the Charnley low-friction hip arthroplasty has a finite life span.     

Results of cemented metal-backed acetabular components: A 10-year-average follow-up study

The clinical and radiographic results of 86 primary total hip arthroplasties performed in 74 patients from 1983 to 1987 with a cemented metal-backed acetabular component and a cemented collared straight femoral stem with a 32-mm head were reviewed at a mean follow-up of 10.1 years. Seven patients (9.2%) underwent acetabular component revision at a mean of 9.0 years after implantation; an additional 24 components (31.6%) demonstrated evidence of radiographic loosening, resulting in a total failure rate of 40.8%. Periacetabular radiolucencies were noted in Charnley zones at the following rates: 34.2% in zone I, 18.4% in zone II, and 27.6% in zone III. In addition, 18.4% and 38.2% of implants demonstrated evidence of migration and excessive polyethylene wear. Excessively vertical cup placement (>49° inclination) at the time of initial arthroplasty was statistically correlated with polyethylene wear, implant migration, and fixation failure. A trend of increasing implant failure was also noted with decreasing polyethylene liner thickness. Periacetabular cement mantle thickness was not statistically correlated with subsequent component loosening or failure. Results of Kaplan-Meier survivorship analysis using revision as an endpoint showed 93.6% survivorship at 10 years and 88.4% at 12 years. The mean modified Harris hip scores were 46.9 preoperatively and 81.8 at final follow-up. The significant overall rates of radiographic loosening, migration, polyethylene wear, and implant revision confirm the suspected trend of increasing failure rates of cemented metal-backed acetabular components over time.     

国产表面多孔解剖型全髋关节置换术的远期随访结果

目的 评估国产表面多孔解剖型全髋关节置换术的远期疗效.方法 1990年1月至1998年4月接受国产表面多孔解剖型全髋关节置换术的95例患者经电话核实、预约及直接去患者家中随访,同时在当地医院拍摄标准髋关节正侧位X线片.随访指标:依据Harris评分评价临床疗效,应用Gruen和DeLee & Chamley分区法对股骨柄和髋臼杯的正侧位X线影像进行分析.结果 50例失随访,16例死亡.29例(37髋)得到随访,随访时间11～17年,平均13.8年.随访时4例4髋已得到翻修,其余患者随访时Harris评分6～98分,平均70.3分;其中优7例10髋,良4例6髋,中5例7髋,差9例10髋,优良率48.5%.6髋(18.2%)需行翻修,主要原因为假体无菌性松动及移位.按照Harris评分标准,患者术髋无疼痛或轻度疼痛18例,中度以上疼痛6例(偶服比阿司匹林强的镇痛剂),病废1例(因疼痛被迫卧床,卧床也有剧痛).X线片显示股骨柄下沉9髋,平均下沉9.3mm;股骨柄周围出现透光带12髋;股骨柄周围骨溶解10髋;髋臼假体侧出现透光带13髋;假体多孔表面层有不同程度脱落2髋.结论 20世纪90年代应用的国产表面多孔解剖型全髋关节置换术可有效改善患者功能,但其远期疗效还有待进一步提高.假体无菌性松动是其最主要的远期并发症.     

Midterm Clinical and Radiographic Outcomes of a Contemporary Monoblock Dual-Mobility Cup in Uncemented Total Hip Arthroplasty

BackgroundThe efficacy of contemporary monoblock dual-mobility (DM) cups to prevent dislocations in total hip arthroplasty (THA) is well reported, but there is little published data on their mid- to long-term outcomes. The authors aimed at reporting the 10-year survival of a contemporary DM cup as well as its clinical and radiographic outcomes.MethodsFrom a retrospective consecutive multicentric series of 516 patients (541 hips) that received uncemented THA between June 2007 and June 2010, 6 patients (6 hips) had cup and stem revisions, 5 patients (5 hips) had isolated stem revision, and 2 patients (2 hips) had isolated insert revision. A total of 103 patients (111 hips) died with their original implants, and 41 patients (42 hips) were lost to follow-up. This left 358 patients (375 hips) for clinical assessment at a median follow-up of 8.7 years (range, 6.8-10.5 years), including 279 patients (290 hips) with postoperative radiographs. Implant survival was calculated using the Kaplan-Meier method, and multivariable analyses were performed to determine whether clinical outcomes are associated with patient or surgical factors.ResultsThe 10-year survival considering revision for aseptic loosening as end point was 100% for the cup and 99.2% for the stem. No dislocations were observed, and radiographic assessment revealed 1 acetabular granuloma (0.3%), but no radiolucencies nor fractures. The Harris hip score improved from 49.6 ± 15.5 to 85.2 ± 14.5, and the postoperative Oxford hip score was 19.2 ± 7.6. Multivariable analyses revealed that improvement in Harris hip score increased with cup diameter (beta, 1.28; P = .039).ConclusionOur data confirmed satisfactory midterm outcomes of uncemented THA using a contemporary DM cup, with no dislocations nor cup revisions due to aseptic loosening.Level of EvidenceLevel IV, retrospective cohort study.     

无柄人工髋关节置换术的初步临床应用

目的 评价无柄人工髋关节置换术的早期随访结果,探讨其临床应用的安全性及可行性.方法 2002年2月至2007年3月,对51例56髋施行无柄人工髋关节置换术.男31例34髋,女20例22髋;年龄25～87岁,平均56.2岁.术前髋关节Harris评分平均(72.4±8.4)分.新鲜股骨颈骨折6例6髋,股骨颈骨折继发股骨头坏死4例4髋,股骨头缺血性坏死(FicatⅢ-Ⅳ期)34例37髋,强直性脊柱炎髋关节强直2例3髋,类风湿髋关节炎2例3髋,髋关节结核3例3髋.全髋关节置换50髋,半髋关节置换6髋.以Harris评分评价术后疗效,用Amstutz分区方法对X线片进行分区评价,观察假体位置及并发症情况.结果 全部病例随访2～7年,平均4.8年.髋关节Harris评分平均(92.8+3.2)分,其中优44髋、良7髋、可4髋、差1例,优良率91%.术后第2,3天发生关节脱位2例,经手法复位成功;术后40天发生感染1例,行关节腔病灶清除及持续关节腔冲洗后治愈;术后半年髋区疼痛1例,行有柄全髋关节翻修.随访期间X线片未见关节松动、脱位及螺钉松动、断裂等情况.结论 无柄人工髋关节置换术可保留股骨颈,创伤小、出血少易于于翻修,适合高龄体弱及年轻患者.早期疗效可靠,远期疗效有待进一步观察.     

Hydroxyapatite-coated total hip arthroplasty: the impact on thigh pain and arthroplasty survival

The purpose of this study was to evaluate the long-term clinical outcomes of primary total hip arthroplasty using an uncemented, hydroxyapatite-coated implant. We followed a consecutive series of 164 patients, who underwent total hip arthroplasty with the Furlong fully-hydroxyapatite coated implant over a mean time period of 12.8 years. Clinical and radiological analyses were performed. Roentgenographic evaluation for the femoral side of the hip was performed using the Gruen zones, for the acetabular side using the DeLee and Charnley zones. Engh's radiological score was employed to assess fixation and stability of the stem. Clinical results were evaluated by Harris Hip Score. The mean Harris hip score was 46 preoperatively and 85 at last follow-up. The mean Engh score was 23. No hips had been revised for aseptic loosening of the femoral component. Thigh pain incidence was very low (1.2%). Survival analysis showed excellent results (95.8% at end point). The Furlong hydroxyapatite-coated implant appears as a reliable and safe option for hip arthroplasty.